Kaleido Biosciences, Inc.KLDOOTCMARKET
Loading
SG&A Expenses Over TimeContracting
Percentile Rank60
3Y CAGR+4.0%
5Y CAGR+67.9%
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+4.0%/yr
Annual compound
5Y CAGR
+67.9%/yr
Recent deceleration
Percentile
P60
Within normal range
vs 5Y Ago
13.3x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2021$20.97M-12.2%
2020$23.88M+6.5%
2019$22.43M+20.4%
2018$18.62M+208.4%
2017$6.04M+283.9%
2016$1.57M-